Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

91 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Expression and androgenic regulation of human prostate-specific kallikreins.
Young CY, Andrews PE, Tindall DJ. Young CY, et al. Among authors: andrews pe. J Androl. 1995 Mar-Apr;16(2):97-9. J Androl. 1995. PMID: 7559150 Review.
Tissue-specific and hormonal regulation of human prostate-specific glandular kallikrein.
Young CY, Andrews PE, Montgomery BT, Tindall DJ. Young CY, et al. Among authors: andrews pe. Biochemistry. 1992 Jan 28;31(3):818-24. doi: 10.1021/bi00118a026. Biochemistry. 1992. PMID: 1370633
Tumor-promoting phorbol ester down-regulates the androgen induction of prostate-specific antigen in a human prostatic adenocarcinoma cell line.
Andrews PE, Young CY, Montgomery BT, Tindall DJ. Andrews PE, et al. Cancer Res. 1992 Mar 15;52(6):1525-9. Cancer Res. 1992. PMID: 1371717
Hormonal regulation of prostate-specific antigen (PSA) glycoprotein in the human prostatic adenocarcinoma cell line, LNCaP.
Montgomery BT, Young CY, Bilhartz DL, Andrews PE, Prescott JL, Thompson NF, Tindall DJ. Montgomery BT, et al. Among authors: andrews pe. Prostate. 1992;21(1):63-73. doi: 10.1002/pros.2990210107. Prostate. 1992. PMID: 1379363
Hormonal regulation of prostate-specific antigen messenger RNA in human prostatic adenocarcinoma cell line LNCaP.
Young CY, Montgomery BT, Andrews PE, Qui SD, Bilhartz DL, Tindall DJ. Young CY, et al. Among authors: andrews pe. Cancer Res. 1991 Jul 15;51(14):3748-52. Cancer Res. 1991. PMID: 1712248
Preoperative androgen deprivation therapy: artificial lowering of serum prostate specific antigen without downstaging the tumor.
Oesterling JE, Andrews PE, Suman VJ, Zincke H, Myers RP. Oesterling JE, et al. Among authors: andrews pe. J Urol. 1993 Apr;149(4):779-82. doi: 10.1016/s0022-5347(17)36206-7. J Urol. 1993. PMID: 7681117
Antagonism of androgen action in prostate tumor cells by retinoic acid.
Young CY, Murtha PE, Andrews PE, Lindzey JK, Tindall DJ. Young CY, et al. Among authors: andrews pe. Prostate. 1994 Jul;25(1):39-45. doi: 10.1002/pros.2990250106. Prostate. 1994. PMID: 8022710
Radiotherapy for men with isolated increase in serum prostate specific antigen after radical prostatectomy.
Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Macdonald OK, et al. Among authors: andrews pe. J Urol. 2003 Nov;170(5):1833-7. doi: 10.1097/01.ju.0000091835.80547.a4. J Urol. 2003. PMID: 14532786
Salvage radiotherapy for palpable, locally recurrent prostate cancer after radical prostatectomy.
Macdonald OK, Schild SE, Vora SA, Andrews PE, Ferrigni RG, Novicki DE, Swanson SK, Wong WW. Macdonald OK, et al. Among authors: andrews pe. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1530-5. doi: 10.1016/j.ijrobp.2003.09.082. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050333 Review.
Prostate cancer and the role of biomarkers.
Nevo A, Navaratnam A, Andrews P. Nevo A, et al. Among authors: andrews p. Abdom Radiol (NY). 2020 Jul;45(7):2120-2132. doi: 10.1007/s00261-019-02305-8. Abdom Radiol (NY). 2020. PMID: 31720770 Review.
91 results
Jump to page
Feedback